Skip to main content
Top
Published in: BMC Public Health 1/2024

Open Access 01-12-2024 | Opioids | Research

Prescription drug monitoring programs and prescription pain medication misuse among U.S. high school students—2019

Authors: Kevin Liu, Marco Benedetti, Alexander Evans, Motao Zhu

Published in: BMC Public Health | Issue 1/2024

Login to get access

Abstract

Background

Prescription drug monitoring programs (PDMPs) are state-level databases that track and inform prescribing practices to reduce prescription drug diversion and misuse. To our knowledge, only three studies have examined the impact of PDMPs on opioid-related outcomes among adolescents, and none have focused on prescription pain medication misuse among adolescents.

Methods

This study leveraged data from the 2019 National Youth Risk Behavior Survey (YRBS) to explore the associations between five categories of PDMP dimensions and the prevalence of self-reported prescription pain medication misuse. Demographic factors’ associations with self-reported prescription pain medication misuse were also examined.

Results

In 2019, none of the PDMP dimensions were associated with self-reported prescription pain medication misuse among U.S. high school students, adjusting for gender, grade, race/ethnicity, and sexual orientation.

Conclusions

None of the five PDMP dimensions were associated with lower prescription pain medication misuse, however further research is needed, especially as new YRBS data become available.
Literature
1.
go back to reference McCabe SE, Boyd CJ, Evans-Polce RJ, McCabe VV, Schulenberg JE, Veliz PT. Pills to powder: a 17-Year transition from prescription opioids to Heroin among US adolescents followed into Adulthood. J Addict Med 2021 May-Jun 01;15(3):241–4. https://doi.org/10.1097/ADM.0000000000000741. PMID: 32991383; PMCID: PMC7987892. McCabe SE, Boyd CJ, Evans-Polce RJ, McCabe VV, Schulenberg JE, Veliz PT. Pills to powder: a 17-Year transition from prescription opioids to Heroin among US adolescents followed into Adulthood. J Addict Med 2021 May-Jun 01;15(3):241–4. https://​doi.​org/​10.​1097/​ADM.​0000000000000741​. PMID: 32991383; PMCID: PMC7987892.
2.
go back to reference Clayton HB, Bohm MK, Lowry R, Ashley C, Ethier KA. Prescription opioid misuse associated with risk behaviors among adolescents. Am J Prev Med. 2019;57:533–9.CrossRefPubMed Clayton HB, Bohm MK, Lowry R, Ashley C, Ethier KA. Prescription opioid misuse associated with risk behaviors among adolescents. Am J Prev Med. 2019;57:533–9.CrossRefPubMed
3.
go back to reference Cerda M, Santaella J, Marshall BD, Kim JH, Martins SS. Nonmedical prescription opioid use in childhood and early adolescence predicts transitions to heroin use in young adulthood: a national study. J Pediatr. 2015;167:605–e121.CrossRefPubMedPubMedCentral Cerda M, Santaella J, Marshall BD, Kim JH, Martins SS. Nonmedical prescription opioid use in childhood and early adolescence predicts transitions to heroin use in young adulthood: a national study. J Pediatr. 2015;167:605–e121.CrossRefPubMedPubMedCentral
4.
go back to reference Jones CM, Christensen A, Gladden RM. Increases in prescription opioid injection abuse among treatment admissions in the United States, 2004–2013. Drug Alcohol Depend. 2017;176:89–95.CrossRefPubMedPubMedCentral Jones CM, Christensen A, Gladden RM. Increases in prescription opioid injection abuse among treatment admissions in the United States, 2004–2013. Drug Alcohol Depend. 2017;176:89–95.CrossRefPubMedPubMedCentral
5.
go back to reference Fink DS, Schleimer JP, Sarvet A, et al. Association between Prescription Drug Monitoring Programs and Nonfatal and Fatal Drug overdoses: a systematic review. Ann Intern Med. 2018;168(11):783–90.CrossRefPubMedPubMedCentral Fink DS, Schleimer JP, Sarvet A, et al. Association between Prescription Drug Monitoring Programs and Nonfatal and Fatal Drug overdoses: a systematic review. Ann Intern Med. 2018;168(11):783–90.CrossRefPubMedPubMedCentral
6.
go back to reference Finley EP, Garcia A, Rosen K, et al. Evaluating the impact of prescription drug monitoring program implementation: a scoping review. BMC Health Serv Res. 2017;17(1):420.CrossRefPubMedPubMedCentral Finley EP, Garcia A, Rosen K, et al. Evaluating the impact of prescription drug monitoring program implementation: a scoping review. BMC Health Serv Res. 2017;17(1):420.CrossRefPubMedPubMedCentral
7.
go back to reference Cerdá M, Ponicki WR, Smith N, et al. Measuring relationships between proactive reporting state-level prescription drug Monitoring Programs and County-level fatal prescription opioid overdoses. Epidemiology. 2020;31(1):32–42.CrossRefPubMedPubMedCentral Cerdá M, Ponicki WR, Smith N, et al. Measuring relationships between proactive reporting state-level prescription drug Monitoring Programs and County-level fatal prescription opioid overdoses. Epidemiology. 2020;31(1):32–42.CrossRefPubMedPubMedCentral
8.
go back to reference Ali M, Dowd W, Classen T, Mutter R, Novak S. Prescription drug monitoring programs, nonmedical use of prescription drugs, and heroin use: evidence from the National Survey of Drug Use and Health. Addict Behav. 2017;69:65–77.CrossRefPubMed Ali M, Dowd W, Classen T, Mutter R, Novak S. Prescription drug monitoring programs, nonmedical use of prescription drugs, and heroin use: evidence from the National Survey of Drug Use and Health. Addict Behav. 2017;69:65–77.CrossRefPubMed
9.
go back to reference Hudgins JD, Porter JJ, Monuteaux MC, Bourgeois FT. Prescription opioid use and misuse among adolescents and young adults in the United States: a national survey study. PLoS Med. 2019;16:11.CrossRef Hudgins JD, Porter JJ, Monuteaux MC, Bourgeois FT. Prescription opioid use and misuse among adolescents and young adults in the United States: a national survey study. PLoS Med. 2019;16:11.CrossRef
10.
go back to reference Earlywine JJ, Hadland SE, Raifman J. State-level prescription drug monitoring program mandates and adolescent injection drug use in the United States, 1995–2017: a difference-in-differences analysis. PLoS Med. 2020;17(9):e1003272.CrossRefPubMedPubMedCentral Earlywine JJ, Hadland SE, Raifman J. State-level prescription drug monitoring program mandates and adolescent injection drug use in the United States, 1995–2017: a difference-in-differences analysis. PLoS Med. 2020;17(9):e1003272.CrossRefPubMedPubMedCentral
11.
go back to reference Toce MS, Michelson K, Hudgins J, et al. Association of State-Level opioid-reduction policies with Pediatric Opioid Poisoning. JAMA Pediatr. 2020;174(10):961–8.CrossRefPubMed Toce MS, Michelson K, Hudgins J, et al. Association of State-Level opioid-reduction policies with Pediatric Opioid Poisoning. JAMA Pediatr. 2020;174(10):961–8.CrossRefPubMed
12.
go back to reference Theodorou CM, Jackson JE, Rajasekar G, et al. Impact of prescription drug monitoring program mandate on postoperative opioid prescriptions in children. Pediatr Surg Int. 2021;37(5):659–65.CrossRefPubMedPubMedCentral Theodorou CM, Jackson JE, Rajasekar G, et al. Impact of prescription drug monitoring program mandate on postoperative opioid prescriptions in children. Pediatr Surg Int. 2021;37(5):659–65.CrossRefPubMedPubMedCentral
13.
go back to reference Underwood JM, Brener N, Thornton J, et al. Overview and methods for the Youth Risk Behavior Surveillance System — United States, 2019. MMWR Suppl. 2020;69(Suppl–1):1–10.CrossRefPubMedPubMedCentral Underwood JM, Brener N, Thornton J, et al. Overview and methods for the Youth Risk Behavior Surveillance System — United States, 2019. MMWR Suppl. 2020;69(Suppl–1):1–10.CrossRefPubMedPubMedCentral
14.
go back to reference Jones CM, Clayton HB, Deputy NP, et al. Prescription opioid misuse and use of Alcohol and other substances among High School Students — Youth Risk Behavior Survey, United States, 2019. MMWR Suppl. 2020;69(Suppl–1):38–46.CrossRefPubMedPubMedCentral Jones CM, Clayton HB, Deputy NP, et al. Prescription opioid misuse and use of Alcohol and other substances among High School Students — Youth Risk Behavior Survey, United States, 2019. MMWR Suppl. 2020;69(Suppl–1):38–46.CrossRefPubMedPubMedCentral
15.
go back to reference Prescription Drug Monitoring Program Training and Technical Assistance Center. PDMP Policies and Practices. 2022. Accessed July 2021. Prescription Drug Monitoring Program Training and Technical Assistance Center. PDMP Policies and Practices. 2022. Accessed July 2021.
17.
go back to reference Barnett TE, Thompson EL, Litt DM, Lewis MA. Correlates of nonmedical prescription opioid use among U.S. adolescents. Am J Prev Med. 2019;57(5):175–9.CrossRef Barnett TE, Thompson EL, Litt DM, Lewis MA. Correlates of nonmedical prescription opioid use among U.S. adolescents. Am J Prev Med. 2019;57(5):175–9.CrossRef
18.
go back to reference Li DH, Turner BC, Mustanski B, Phillips GL. Sexual orientation disparities in prescription drug misuse among a nationally representative sample of adolescents: prevalence and correlates. Addict Behav. 2018;77:143–51.CrossRefPubMed Li DH, Turner BC, Mustanski B, Phillips GL. Sexual orientation disparities in prescription drug misuse among a nationally representative sample of adolescents: prevalence and correlates. Addict Behav. 2018;77:143–51.CrossRefPubMed
19.
go back to reference Palamar JJ, Shearston JA, Dawson EW, et al. Nonmedical opioid use and heroin use in a nationally representative sample of us high school seniors. Drug Alcohol Depend. 2016;158:132–8.CrossRefPubMed Palamar JJ, Shearston JA, Dawson EW, et al. Nonmedical opioid use and heroin use in a nationally representative sample of us high school seniors. Drug Alcohol Depend. 2016;158:132–8.CrossRefPubMed
Metadata
Title
Prescription drug monitoring programs and prescription pain medication misuse among U.S. high school students—2019
Authors
Kevin Liu
Marco Benedetti
Alexander Evans
Motao Zhu
Publication date
01-12-2024
Publisher
BioMed Central
Keywords
Opioids
Opioids
Published in
BMC Public Health / Issue 1/2024
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-024-18698-1

Other articles of this Issue 1/2024

BMC Public Health 1/2024 Go to the issue